D68.62 Código facturable y específico Lupus anticoagulant syndrome
ICD-10-CM D68.62 identifies “Lupus anticoagulant syndrome” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Instrucciones del código
Inclusion terms2
- Lupus anticoagulant
- Presence of systemic lupus erythematosus [SLE] inhibitor
Excludes 11
lupus anticoagulant (LAC) finding without diagnosis (R76.0)
Instrucciones de niveles superiores
Capítulos 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Excludes 29
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
D68 · Other coagulation defects
Excludes 11
abnormal coagulation profile NOS (R79.1)
D68.6 · Other thrombophilia
Inclusion terms1
Other hypercoagulable states
Referencias del índice oficial
Referencias del índice oficial (8)
Inhibitor, systemic lupus erythematosus(presence of) (1)
- Inhibitor, systemic lupus erythematosus(presence of)Índice de enfermedades
Lupus (4)
- Lupus › anticoagulantÍndice de enfermedades
- Lupus › anticoagulant › with › hypercoagulable stateÍndice de enfermedades
- Lupus › erythematosus(discoid) (local) › systemic › inhibitor(presence of)Índice de enfermedades
- Lupus › erythematosus(discoid) (local) › systemic › inhibitor(presence of) › with › hypercoagulable stateÍndice de enfermedades
Presence(of) (1)
- Presence(of) › systemic lupus erythematosus [SLE] inhibitorÍndice de enfermedades
Syndrome (1)
- Syndrome › Lupus anticoagulantÍndice de enfermedades
System, systemic (1)
- System, systemic › lupus erythematosus › inhibitor presentÍndice de enfermedades
Referencias desde otros códigos (4)
Excludes 2 · lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
Excludes 2 · systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
Excludes 1 · lupus anticoagulant (D68.62)
Excludes 2 · lupus anticoagulant syndrome (D68.62)
Historial
Historial del código
Último cambio registrado · FY2026
Vigente desde
- Cambios en instrucciones
Lupus anticoagulant syndrome
Código de diagnóstico facturable
CDC/NCHS · FY2026Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Cambios en instrucciones |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Sin cambios tabulares |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Sin cambios tabulares |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Sin cambios tabulares |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Cambios en instrucciones heredadas |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Sin cambios tabulares |
| FY2026 | 2025-10-01 | Cambios en instrucciones |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Correspondencias históricas ICD-9 · 2018
Solo correspondencia histórica; no sustituye códigos automáticamente.
- 289.81 · Aproximada
Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.